Compare · CELZ vs SYF
CELZ vs SYF
Side-by-side comparison of Creative Medical Technology Holdings Inc. (CELZ) and Synchrony Financial (SYF): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CELZ and SYF operate in Finance: Consumer Services (Finance), so they compete in similar markets.
- SYF is the larger of the two at $24.52B, about 6382.7x CELZ ($3.8M).
- Over the past year, CELZ is down 71.5% and SYF is up 1.5% - SYF leads by 73.0 points.
- SYF has been more active in the news (18 items in the past 4 weeks vs 7 for CELZ).
- SYF has more recent analyst coverage (25 ratings vs 1 for CELZ).
- Company
- Creative Medical Technology Holdings Inc.
- Synchrony Financial
- Price
- $0.81-0.47%
- $72.90+1.56%
- Market cap
- $3.8M
- $24.52B
- 1M return
- -59.90%
- -4.44%
- 1Y return
- -71.48%
- +1.52%
- Industry
- Finance: Consumer Services
- Finance: Consumer Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2014
- News (4w)
- 7
- 18
- Recent ratings
- 1
- 25
Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem for the treatment of erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine for the treatment of chronic lower back pain; Amniostem for the treatment of strokes, radiation, toxicity, and glioma; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. was incorporated in 1998 and is based in Phoenix, Arizona.
Synchrony Financial
Synchrony Financial operates as a consumer financial services company in the United States. It provides a range of specialized financing programs and consumer banking products to digital, retail, home, auto, travel, health, and pet industries. The company also offers private label credit cards, dual cards, general purpose co-branded credit cards, and small and medium-sized business credit products; and promotional financing for consumer purchases, such as private label credit cards, dual cards, and installment loans. In addition, it provides promotional financing to consumers for health, veterinary and personal care procedures, and services and products, such as dental, vision, audiology, and cosmetic; debt cancellation products; and deposit products, including certificates of deposit, individual retirement accounts, money market accounts, and savings accounts to retail and commercial customers, as well as accepts deposits through third-party securities brokerage firms. The company offers its credit products through programs established with a group of national and regional retailers, local merchants, manufacturers, buying groups, industry associations, and healthcare service providers; and deposit products through various channels, such as digital and print. Synchrony Financial was incorporated in 2003 and is headquartered in Stamford, Connecticut.
Latest CELZ
- SEC Form S-3 filed by Creative Medical Technology Holdings Inc.
- SEC Form DEF 14A filed by Creative Medical Technology Holdings Inc.
- Creative Medical Technology Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Leadership Update, Financial Statements and Exhibits
- SEC Form PRE 14A filed by Creative Medical Technology Holdings Inc.
- Creative Medical Technology Holdings Issues Mid-Year Update
- Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.5 Million Gross Proceeds
- SEC Form RW filed by Creative Medical Technology Holdings Inc.
- Amendment: SEC Form S-1/A filed by Creative Medical Technology Holdings Inc.
- SEC Form S-1 filed by Creative Medical Technology Holdings Inc.
- Creative Medical Technology Holdings Expands ADAPT Trial Under New FDA Clearance and Rapidly Advances Toward Phase 3 Planning for Olastrocel in Chronic Lower Back Pain
Latest SYF
- SEC Form 10-Q filed by Synchrony Financial
- Synchrony Financial filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Synchrony Financial filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Synchrony Reports Second Quarter 2026 Results
- Synchrony Launches Free Skilled-Trades Degree Pathway for Employees
- Director Parker P.W. was granted 789 shares, increasing direct ownership by 2% to 34,475 units (SEC Form 4)
- Director Alves Paget Leonard was granted 789 shares, increasing direct ownership by 2% to 52,383 units (SEC Form 4)
- Director Chytil Kamila K was granted 789 shares, increasing direct ownership by 5% to 17,918 units (SEC Form 4)
- Director Ellinger Deborah G was granted 789 shares, increasing direct ownership by 51% to 2,342 units (SEC Form 4)
- Director Aguirre Fernando was granted 789 shares, increasing direct ownership by 3% to 30,262 units (SEC Form 4)